Back to Search

A Phase 2, Open-Label, Multicenter, Basket Study Evaluating the Efficacy of Brexucabtagene Autoleucel in Adults With Rare B-cell Malignancies (ZUMA-25)


  • Protocol Number: 202212028
  • Principal Investigator: Crees, Zachary
  • Cancer Types: Gene & Cellular Immunotherapy, Leukemia, Myeloma, and Hematologic, Lymphoma

For more information on this trial, contact us here:

Phone
800-600-3606
Email
[email protected]

Brief Summary

Protocol Interventions